Our work in child & adolescent TB
The Union works to develop, test, implement and scale up routine screening of child contacts of people with TB. We run observational studies and advocate to ensure children and adolescents are included in clinical trials that target diagnostics, vaccines and treatment of TB disease and infection.
The Union’s Child and Adolescent Tuberculosis Centre of Excellence is a virtual network of tuberculosis (TB) professionals and organisations in the sub-Sahara Africa region, providing a community of learning and practice for childhood and adolescent TB. It currently covers Ethiopia, Kenya, Malawi, Mozambique, Tanzania, Uganda, Zambia, Eswatini, Zimbabwe.
Other areas of our work in tuberculosis
You might also be interested in our work on drug-resistant TB and TB-HIV, TB-diabetes and co-morbidities.
Two Union-led projects, in Uganda and four french-speaking countries, successfully developed influential models which saw local health workers trained to identify and treat children with TB as well as identifying those who would benefit from TB preventative therapy.
Part of The Union membership TB section, the maternal and child TB working group has provided technical support to countries considering potential safety of intermittent preventive therapy in pregnancy. As advocates, they collected stories from women around the world affected by TB in pregnancy, developed posters for the UNHLM for UNICEF and a briefing document, ‘The Dangers of TB in Pregnancy.’ These resources are available on The Union Childhood TB Learning Portal.
Learn more
Understand the issues with our fact sheets
Child & Adolescent TB Union news
Global reporting on TB in children and adolescents: how far have we come and what remains to be done?
An Editorial in a forthcoming issue of IJTLD Open highlights the need for further progress in tackling TB in children and adolescents. The preprint is free to read.
The second United Nations high-level meeting on the fight to end TB: action is needed to turn the tide by 2030
An Editorial in the September issue of PHA highlights the need to accelerate progress towards TB elimination.
Community perspective on child-friendly medications for drug-resistant TB: importance, priorities and advocacy
An Editorial in a forthcoming issue of the IJTLD highlights the need for child-friendly medications for drug-resistant TB. The preprint is free to read.
Child tuberculosis: Akello's TB preventive therapy story
Akello, 10 years old, is living with HIV. After his mother fled to South Africa to look for work five years ago, he has been living with…